Chronic obstructive pulmonary disease: current burden and future projections Source: Eur Respir J 2006; 27: 397-412 Year: 2006
Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Asthma and chronic obstructive pulmonary disease training in an online environment: a new response to a growing problem Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses Year: 2019
Chronic obstructive pulmonary disease: the patient perspective Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001
Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006
Chronic obstructive pulmonary disease (COPD) in children: is it possible? Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005
Socioeconomic burden of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=463 Year: 2006
Chronic obstructive pulmonary disease: a pharmacy based approach Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007
Chronic obstructive pulmonary disease and tuberculosis: phenotypes, options Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features? Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006
Patient knowledge and awareness of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 621s Year: 2002
Future research in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=470 Year: 2006
Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Negative online images more common in chronic obstructive pulmonary disease (COPD) than asthma or heart disease Source: Virtual Congress 2020 – How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go? Year: 2020
Programme organisation: what and how can we do better? Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines Year: 2007
Chronic obstructive pulmonary disease in workers from different sectors. Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease Year: 2020
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009